Ascletis Pharma-B (01672) received an investment of 64.128 million shares from Singapore's Government Investment Corporation, involving approximately US$100 million

ASCLEPES-B (01672) received an investment of 64.128 million shares from Singapore Government Investment Corporation, involving approximately US$100 million.

According to documents disclosed by the Hong Kong Stock Exchange, Singapore Government Investment Corporation (GIC Private Limited) invested in ASCLEPES, purchasing 64,128,000 ordinary shares at an average price of HK$12.18 per share, totaling approximately HK$781 million, equivalent to about US$100 million. After the investment, GIC holds 64,128,000 shares of ASCLEPES, accounting for approximately 6.42% of the company's issued share capital, officially becoming one of the company's major institutional shareholders.